Advertisement
Please join our staff as we participate or present in the following presentations at the 2017 AUA Annual Meeting
MP49-04: Excised Parenchymal Mass and Devascularized Parenchymal Mass Associated with Partial Nephrectomy: Impact on Functional Recovery
7 – 9 a.m.
Presenting Author: Chalairat Suk-Ouichai
Location: BCEC: Room 252
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
MP49-10: Ischemia and Functional Recovery from Partial Nephrectomy: Refined Perspectives
7 – 9 a.m.
Presenting Author: Chalairat Suk-Ouichai
Location: BCEC: Room 252
MP49-11: Renal Ischemia and Volume Loss Have a Compounding Effect on Acute Renal Dysfunction after Partial Nephrectomy
7 – 9 a.m.
Presenting Author: Julien Dagenais, MD
Location: BCEC: Room 252
MP49-17: Robot-assisted partial nephrectomy for selected renal mass using off-clamp approach offered renal functional advantage over on-clamp
7 – 9 a.m.
Presenting Author: Pascal Mouracade, MD, PhD
Location: BCEC: Room 252
044IC: AUA Guidelines 2017: Evaluation and Management of Localized Renal Mass
7:30 – 9:30 a.m.
Course Director: Steven Campbell, MD
Location: BCEC 258B
MP55-04: Perinephric versus sinus fat invasion in pT3a tumors managed by partial nephrectomy
9:30 – 11:30 a.m.
Presenting Author: Pascal Mouracade, MD, PhD
Location: BCEC: Room 253AB
MP56-12: Concerns of Female Peyronie’s Disease Partners: A Narrative Analysis
1 – 3 p.m.
Presenting Author: Barbara Chubak, MD
Location: BCEC: Room 151
MP59-15: Long−term Outcomes After Renal Cancer Surgery: Predictors of Chronic Kidney Disease and Non−Renal Cancer Mortality
1 – 3 p.m.
Presenting Author: Joseph Zabell, MD
Location: BCEC: Room 160
MP59-16: Vascularized Parenchymal Mass Preservation with Partial Nephrectomy: Functional Impact and Predictive Factors
1 – 3 p.m.
Presenting Author: Jitao Wu, MD
Location: BCEC: Room 160
The Reproductive Risks of Chemo and Radiation therapy for Boys: Lessons Learned from U.S. & Global Cohorts (and data needs for future)
1:20 – 1:35 p.m.
Speaker: Daniel Greene, MD
Location: BCEC: Room 204
Advertisement
Single-site robotic urologic surgery on horizon for clinical use
1:23 – 1:36 p.m.
Speaker: Jihad Kaouk, MD, FACS
Location: Westin Waterfront: Marina Ballroom
Second Opinion Cases: Renal Hilar Mass
1:30 – 2 p.m.
Panelist: Georges-Pascal Haber, MD, PhD
Location: BCEC: Ballroom West
Prostate Cancer – New Markers, Imaging Modalities for Better Diagnosis
2:05 – 3 p.m.
Moderator: Andrew J. Stephenson, MD
Location: Westin Grand Ballroom A
Incorporating mMRI in the Diagnostic Decision Making for Significant Cancer
2:15 – 2:30 p.m.
Speaker: Andrew J. Stephenson, MD
Location: Westin Grand Ballroom A
Panel Discussion on Clinical Cases: What is Your Choice of Treatment
2:30 – 3 p.m.
Moderator: Andrew J. Stephenson, MD
Location: Westin Grand Ballroom A
MP63: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Incontinence: Evaluation (Urodynamic Testing)
3:30 – 5:30 p.m.
Poster Session Moderator: Courtenay K. Moore, MD
Location: BCEC: Room 153
MP67-09: Surveillance strategy and outcome after partial nephrectomy
3:30 – 5:30 p.m.
Presenting Author: Pascal Mouracade, MD, PhD
Location: BCEC: Room 252
Interstitial Cystitis
4:05 – 4:55 p.m.
Moderator: Howard Goldman, MD, FACS
Location: Westin Grand Ballroom A
Management of Interstitial Cystitis – An Evidence Based Approach Utilizing the AUA Guidelines
4:15 – 4:25 p.m.
Speaker: Howard Goldman, MD, FACS
Location: Westin Grand Ballroom A
Panel Discussion on Clinical Cases: How do you treat this patient? Differences in approaches?
4:25 – 4:55 p.m.
Moderator: Howard Goldman, MD, FACS
Location: Westin Grand Ballroom A
Advertisement
Please note: Presentations listed as of May 8, 2017. Date and locations are subject to change.
Advertisement
Advertisement
Retrospective study evaluates clinical upstaging during neoadjuvant treatment
Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy
Revolutionizing pediatric urology with a new, less invasive approach
What updated techniques, counseling and a changing workforce could mean
Applications, outcomes and untapped potential
Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes
Early, individualized diagnosis and comprehensive management key to preserving fertility
Up to 3 days faster than waiting for urine culture results